CSF shunt valve occlusion-does CSF protein and cell count matter?

Area of Science:

• Neurosurgery
• Pediatric Neurosurgery
• Cerebrospinal Fluid Dynamics

Background:

• Shunt obstruction is a primary cause of shunt failure in hydrocephalus management.
• Traditional beliefs link valve occlusion to elevated cerebrospinal fluid (CSF) protein or cells, but evidence is inconsistent.
• This study investigates CSF protein and cell counts as specific risk factors for shunt valve obstruction.

Purpose of the Study:

• To determine the association between CSF protein and cell count and shunt valve obstruction.
• To identify risk factors contributing to early and late shunt valve occlusion.
• To analyze the predictive value of CSF protein levels at shunt insertion for valve occlusion.

Main Methods:

• Retrospective analysis of 274 hydrocephalus patients undergoing shunt placement (2009-2018) with ≥1 year follow-up.
• Evaluation of patient demographics, hydrocephalus etiology, valve type, and CSF parameters (protein, white blood cell count) at insertion and revision.
• Statistical analysis to correlate CSF values and patient characteristics with shunt valve obstruction and revision rates.

Main Results:

• 11.7% of patients (32/274) required revision for valve occlusion, with a mean time to revision of 143 days.
• Elevated CSF white blood cell (WBC) count, but not protein level, was associated with overall valve occlusion.
• Persistently elevated CSF protein at revision surgery predicted early obstruction (<90 days); infants and patients with congenital malformations or post-hemorrhagic hydrocephalus were overrepresented.

Conclusions:

• Pathological CSF WBC count and persistently elevated protein are risk factors for early shunt valve obstruction.
• Late shunt obstruction is independent of normal CSF values.
• Infants face a higher risk of both early and late shunt obstructions; CSF protein at insertion does not predict occlusion.